During the past decade, Fakultni nemocnice u sv Anny v Brne conducted 75 clinical trials. In the 10-year time frame, 75 clinical trials started and 41 clinical trials were completed, i.e. on average, 54.7% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 34 clinical trials were completed. i.e. 97.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fakultni nemocnice u sv Anny v Brne" #1 sponsor was "Eli Lilly and Company" with 9 trials, followed by "Pfizer" with 9 trials sponsored, "Hoffmann-La Roche" with 8 trials sponsored, "Bayer" with 5 trials sponsored and "Amgen" with 5 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fakultni nemocnice u sv Anny v Brne" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "ABX CRO" with 1 trials as a collaborator, "AG Mednet Inc." with 1 trials as a collaborator and "Advanced Clinical, LLC" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Fakultni nemocnice u sv Anny v Brne" are "Ulcerative Colitis" (10 trials), "Multiple Sclerosis" (9 trials), "Crohn Disease" (4 trials), "Atopic Dermatitis" (3 trials) and "Crohn's Disease" (3 trials). Many other conditions were trialed in "Fakultni nemocnice u sv Anny v Brne" in a lesser frequency.

Most popular intervention types in "Fakultni nemocnice u sv Anny v Brne" are "Drug" (78 trials), "Other" (10 trials), "Device" (8 trials), "Biological" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "Mirikizumab" (6 trials), "Mavenclad®" (4 trials), "Etrasimod" (3 trials) and "ABX464" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fakultni nemocnice u sv Anny v Brne" are 94 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Fakultni nemocnice u sv Anny v Brne". undefined are not yet recruiting, 20 are recruiting, 13 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 47 completed trials in Fakultni nemocnice u sv Anny v Brne, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Fakultni nemocnice u sv Anny v Brne, 2 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 6 trials that are defined as “Not Applicable".

Fakultni nemocnice u sv Anny v Brne has several departments that took part in Clinical trials: "Fakultni nemocnice u sv. Anny Neurologicka klinika" - 8 trials, "Fakultni nemocnice u sv. Anny v Brne; I.Interni kardioangiologicka klinika" - 3 trials